HOW MONSANTO FOUGHT A NEGATIVE ASSESSMENT OF ROUNDUP ACTIVE INGREDIENT GLYPHOSATE | WHAT REALLY HAPPENED


HOW MONSANTO FOUGHT A NEGATIVE ASSESSMENT OF ROUNDUP ACTIVE INGREDIENT GLYPHOSATE

In March 2015, agrochemical giant Monsanto had a problem. The World Health Organization's International Agency for Research on Cancer (IARC) announced that glyphosate, the principal ingredient in Monsanto's Roundup weed-killer product, was probably carcinogenic to humans.

Negative results from the IARC panel, which identifies and evaluates environmental causes of cancer in humans, could mean a potential hit to the company's profitability. Roundup is a major profit generator for Monsanto. In 2015, Monsanto made nearly $4.76 billion US in sales and $1.9 billion in gross profits from its "agricultural productivity" sector, a large part of which was made up of Roundup sales, according to a filing with the U.S. Securities and Exchange Commission.

A review by CBC/Radio-Canada of internal Monsanto documents disclosed in the court case of Dewayne Johnson, who sued Monsanto and won $78 million last October, showed the many efforts the company took to fight the IARC assessment.

The documents also reveal communications between Monsanto and a Canadian firm hired to recruit scientists to publish studies that ultimately defended glyphosate — some of which were secretly reviewed by Monsanto prior to publication. All those papers, as previously reported by CBC/Radio-Canada, were also used as part of Health Canada's re-approval process of glyphosate in 2017.

Webmaster's Commentary: 

This is a company which should be completely sued out of existence, for the horrible cases of cancer it has created for people using it.

And not only should it be sued out of existence, but also, all executives who signed off on the fake reality that it was non-toxic, should spend some very long time in jails, to insure that nothing lie this ever happens again.

Comments

SHARE THIS ARTICLE WITH YOUR SOCIAL MEDIA